AP
RDY icon

Atwood & Palmer’s Dr. Reddy's Laboratories RDY Stock Holding History

Atwood & Palmer’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-250
Closed -$2K – 385
2014
Q2 		$2K Buy
+250
New +$2.1K ﹤0.01% 315

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Atwood & Palmer's RDY Position: Q3 2014 in Review

Atwood & Palmer sold out of Dr. Reddy's Laboratories (RDY) in Q3 2014, closing a stake of 250 shares — an estimated $2K sold.

Atwood & Palmer first reported a position in RDY in Q2 2014 and held it in 1 quarter. The position peaked at $2K in Q2 2014. 159 funds tracked by Wall St. Rank hold RDY as of Q3 2014.

  • Atwood & Palmer reported no remaining Dr. Reddy's Laboratories position as of Q3 2014 after selling out during the quarter.
  • Atwood & Palmer sold 250 Dr. Reddy's Laboratories shares in Q3 2014, an estimated $2K.
  • Atwood & Palmer first reported a position in Dr. Reddy's Laboratories in Q2 2014 and held it in 1 quarter.
  • Atwood & Palmer's Dr. Reddy's Laboratories position peaked at $2K in Q2 2014.
  • 159 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2014.

Based on Atwood & Palmer's 13F filing for Q3 2014, filed 12 Nov 2014.